Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Gemcabene for hypercholesterolemia
NCT02571257Phase 2Completed
- Sponsor
- NeuroBo Pharmaceuticals
- Start
- Aug 2000
- Primary completion
- Apr 2002
- Modality
- Small Molecules
01
Overview
Phase 2, randomised, double-blind trial of gemcabene in hypercholesterolemia (3 arms), sponsored by NeuroBo Pharmaceuticals. Primary endpoint: Low-Density Lipoprotein Cholesterol at 8 weeks. Started Aug 2000; status: completed.
02
Drugs
gemcabene
03
Conditions
hypercholesterolemia
Beyond the preview
Go deeper on NCT02571257.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02571257.